The Long Run with Luke Timmerman

Timmerman Report

"The Long Run" Antarctic explorer Ernest Shackle…

  • 1 hour 11 minutes
    Ep167: Leslie Williams on transfer RNA therapies
    Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.
    6 November 2024, 12:00 am
  • 1 hour 3 minutes
    Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
    Chris Garcia, professor at Stanford University and co-founder of several biotech startups, on using protein engineering to advance new treatments for cancer and autoimmune diseases.
    15 October 2024, 9:48 pm
  • 1 hour 2 minutes
    Ep165: Zach Hornby on Tackling Cancer Drug Resistance
    Zach Hornby, CEO of San Diego-based Boundless Bio, on tackling cancer drug resistance.
    26 September 2024, 1:01 pm
  • 56 minutes 39 seconds
    Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
    Ted Love, chairman of BIO, and Dr. Alan Anderson, executive director of Sickle Forward, on how to improve quality of life for sickle cell disease patients around the world.
    5 September 2024, 12:34 pm
  • 1 hour 8 minutes
    Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
    Sarah Boyce, CEO of San Diego-based Avidity Biosciences, on RNA medicines for rare muscle diseases.
    14 August 2024, 12:46 pm
  • 1 hour 5 minutes
    Ep162: Sean McClain on AI for Biologic Drug Discovery
    Sean McClain, CEO of Absci, on using AI to speed up biologic drug discovery.
    16 July 2024, 4:13 pm
  • 1 hour 8 minutes
    Ep161: Jeff Stein on a Long-Lasting Flu Drug
    Jeff Stein, CEO of San Diego-based Cidara Therapeutics, on a long-lasting drug against flu.
    1 July 2024, 12:35 am
  • 1 hour 8 minutes
    Ep160: Abe Ceesay on Precision Neuroscience
    Abe Ceesay, CEO of Boston-based Rapport Therapeutics, on a precision medicine approach to neuroscience drug discovery.
    17 June 2024, 12:57 pm
  • 1 hour 7 minutes
    Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
    Jimi Olaghere is one of the first patients to have been functionally cured of sickle cell disease with a CRISPR gene-edited cell therapy.
    3 June 2024, 12:40 pm
  • 1 hour 44 seconds
    Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
    David Younger and Randolph Lopez, co-founders of A-Alpha Bio, on using synthetic biology and AI to discover new biologic drugs.
    20 May 2024, 2:09 pm
  • 56 minutes 33 seconds
    Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
    Vineeta Agarwala, general partner at A16Z's Bio & Health fund, on investing in AI for drug discovery.
    1 May 2024, 6:48 pm
  • More Episodes? Get the App
© MoonFM 2024. All rights reserved.